Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations

Early onset of type 2 diabetes and a high prevalence of co‐morbidities predispose the Asian population to a high risk for, and rapid progression of, diabetic kidney disease (DKD). Apart from renin‐angiotensin system inhibitors, sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors have been shown to d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes Obes Metab
Egile Nagusiak: Khoo, Chin Meng, Deerochanawong, Chaicharn, Chan, Siew Pheng, Matawaran, Bien, Sheu, Wayne Huey‐Herng, Chan, Juliana, Mithal, Ambrish, Luk, Andrea, Suastika, Ketut, Yoon, Kun‐Ho, Ji, Linong, Man, Nguyen Huu, Pollock, Carol
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Publishing Ltd 2020
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839543/
https://ncbi.nlm.nih.gov/pubmed/33155749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14251
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak